Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes

Antihistamines and glucocorticoids (GCs) are often used together in the clinic to treat several inflammation-related situations. Although there is no rationale for this association, clinical practice has assumed that, due to their concomitant anti-inflammatory effects, there should be an intrinsic b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carlos Daniel Zappia, Valeria Torralba-Agu, Emiliana Echeverria, Carlos P. Fitzsimons, Natalia Fernández, Federico Monczor
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/5b7ba3c60a49436aa5431328493637c9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5b7ba3c60a49436aa5431328493637c9
record_format dspace
spelling oai:doaj.org-article:5b7ba3c60a49436aa5431328493637c92021-11-25T17:10:32ZAntihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes10.3390/cells101130262073-4409https://doaj.org/article/5b7ba3c60a49436aa5431328493637c92021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3026https://doaj.org/toc/2073-4409Antihistamines and glucocorticoids (GCs) are often used together in the clinic to treat several inflammation-related situations. Although there is no rationale for this association, clinical practice has assumed that, due to their concomitant anti-inflammatory effects, there should be an intrinsic benefit to their co-administration. In this work, we evaluated the effects of the co-treatment of several antihistamines on dexamethasone-induced glucocorticoid receptor transcriptional activity on the expression of various inflammation-related genes in A549 and U937 cell lines. Our results show that all antihistamines potentiate GCs’ anti-inflammatory effects, presenting ligand-, cell- and gene-dependent effects. Given that treatment with GCs has strong adverse effects, particularly on bone metabolism, we also examined the impact of antihistamine co-treatment on the expression of bone metabolism markers. Using MC3T3-E1 pre-osteoblastic cells, we observed that, though the antihistamine azelastine reduces the expression of dexamethasone-induced bone loss molecular markers, it potentiates osteoblast apoptosis. Our results suggest that the synergistic effect could contribute to reducing GC clinical doses, ineffective by itself but effective in combination with an antihistamine. This could result in a therapeutic advantage, as the addition of an antihistamine may reinforce the wanted effects of GCs, while related adverse effects could be diminished or at least mitigated. By modulating the patterns of gene activation/repression mediated by GR, antihistamines could enhance only the desired effects of GCs, allowing their effective dose to be reduced. Further research is needed to correctly determine the clinical scope, benefits, and potential risks of this therapeutic strategy.Carlos Daniel ZappiaValeria Torralba-AguEmiliana EcheverriaCarlos P. FitzsimonsNatalia FernándezFederico MonczorMDPI AGarticleinflammationdexamethasoneantihistaminesglucocorticoidshistamineBiology (General)QH301-705.5ENCells, Vol 10, Iss 3026, p 3026 (2021)
institution DOAJ
collection DOAJ
language EN
topic inflammation
dexamethasone
antihistamines
glucocorticoids
histamine
Biology (General)
QH301-705.5
spellingShingle inflammation
dexamethasone
antihistamines
glucocorticoids
histamine
Biology (General)
QH301-705.5
Carlos Daniel Zappia
Valeria Torralba-Agu
Emiliana Echeverria
Carlos P. Fitzsimons
Natalia Fernández
Federico Monczor
Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
description Antihistamines and glucocorticoids (GCs) are often used together in the clinic to treat several inflammation-related situations. Although there is no rationale for this association, clinical practice has assumed that, due to their concomitant anti-inflammatory effects, there should be an intrinsic benefit to their co-administration. In this work, we evaluated the effects of the co-treatment of several antihistamines on dexamethasone-induced glucocorticoid receptor transcriptional activity on the expression of various inflammation-related genes in A549 and U937 cell lines. Our results show that all antihistamines potentiate GCs’ anti-inflammatory effects, presenting ligand-, cell- and gene-dependent effects. Given that treatment with GCs has strong adverse effects, particularly on bone metabolism, we also examined the impact of antihistamine co-treatment on the expression of bone metabolism markers. Using MC3T3-E1 pre-osteoblastic cells, we observed that, though the antihistamine azelastine reduces the expression of dexamethasone-induced bone loss molecular markers, it potentiates osteoblast apoptosis. Our results suggest that the synergistic effect could contribute to reducing GC clinical doses, ineffective by itself but effective in combination with an antihistamine. This could result in a therapeutic advantage, as the addition of an antihistamine may reinforce the wanted effects of GCs, while related adverse effects could be diminished or at least mitigated. By modulating the patterns of gene activation/repression mediated by GR, antihistamines could enhance only the desired effects of GCs, allowing their effective dose to be reduced. Further research is needed to correctly determine the clinical scope, benefits, and potential risks of this therapeutic strategy.
format article
author Carlos Daniel Zappia
Valeria Torralba-Agu
Emiliana Echeverria
Carlos P. Fitzsimons
Natalia Fernández
Federico Monczor
author_facet Carlos Daniel Zappia
Valeria Torralba-Agu
Emiliana Echeverria
Carlos P. Fitzsimons
Natalia Fernández
Federico Monczor
author_sort Carlos Daniel Zappia
title Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
title_short Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
title_full Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
title_fullStr Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
title_full_unstemmed Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
title_sort antihistamines potentiate dexamethasone anti-inflammatory effects. impact on glucocorticoid receptor-mediated expression of inflammation-related genes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/5b7ba3c60a49436aa5431328493637c9
work_keys_str_mv AT carlosdanielzappia antihistaminespotentiatedexamethasoneantiinflammatoryeffectsimpactonglucocorticoidreceptormediatedexpressionofinflammationrelatedgenes
AT valeriatorralbaagu antihistaminespotentiatedexamethasoneantiinflammatoryeffectsimpactonglucocorticoidreceptormediatedexpressionofinflammationrelatedgenes
AT emilianaecheverria antihistaminespotentiatedexamethasoneantiinflammatoryeffectsimpactonglucocorticoidreceptormediatedexpressionofinflammationrelatedgenes
AT carlospfitzsimons antihistaminespotentiatedexamethasoneantiinflammatoryeffectsimpactonglucocorticoidreceptormediatedexpressionofinflammationrelatedgenes
AT nataliafernandez antihistaminespotentiatedexamethasoneantiinflammatoryeffectsimpactonglucocorticoidreceptormediatedexpressionofinflammationrelatedgenes
AT federicomonczor antihistaminespotentiatedexamethasoneantiinflammatoryeffectsimpactonglucocorticoidreceptormediatedexpressionofinflammationrelatedgenes
_version_ 1718412651778801664